Medical University of Graz

Medizinische Universität Graz

Medizinische Universität Graz
Universitaetsplatz 3
8010 Graz

Principal Investigator

Prof. Kurt Zatloukal

Prof. Kurt Zatloukal

Phone +43-316-380-4404


Institute Presentation

The Medical University of Graz (MUG) (http:/ is associated with the University Clinics of Graz, with 1600 beds and 78000 patients per year. This facilitates close integration of research and routine clinical services. An important asset of the MUG established in an integrated setting of clinical routine and latest medical research is its biobank core-facility, hosting more than 3 million formalin-fixed paraffin-embedded (FFPE) and more than 30,000 cryo-conserved tissue samples. The resources are complemented by latest morphological technologies (Laser capture microdissection, LSM, electron microscopy), SPF facility for animal experiments (tumor xenografts and transgenic models) and ISO-certified RNA and DNA analysis (real-time PCR, DNA microarrays, 454-sequencing) as well as proteomics and metabolomics (lipidomics) platforms.

Kurt Zatloukal is professor of Pathology at MUG and coordinates the preparatory phase of a European biobanking and biomolecular research infrastructure (BBMRI) within the 7th EU framework programme. BBMRI should provide access to high quality human biological samples to enable future needs of large genetic epidemiology and sequencing studies. In this context it is crucial to establish Europe-wide harmonised processes and quality criteria that are compliant with the requirements of latest -omics technologies as well as with ethical and legal regulations. Furthermore, he leads in the FP7-funded large integrated project SPIDIA the development of new European standards and norms for pre-analytical processing of tissue samples.

Kurt Zatloukal was member of the OECD task force on biological resource centres and the Roadmap Working Group of the European Strategy Forum on Research Infrastructures. Moreover, he is member of the steering committee of the P3G consortium, contributed to the OECD best practice guidelines for biological resource centres, the regulations for genetic testing of the Austrian Gene Technology Law, and the opinion on Biobanks for research of the Bioethics Commission at the Austrian Federal Chancellery.

MUG will be responsible for fulfilling the tasks of WP5, efficient networking with biobanks.